Submitted by Anonymous (not verified) on 27 September 2023 - 10:45
Human medicines European public assessment report (EPAR): Vosevi, sofosbuvir,velpatasvir,voxilaprevi, Hepatitis C, Chronic, Date of authorisation: 26/07/2017, Revision: 16, Status: Authorised
Source: